PapersFlow Research Brief
Cancer, Lipids, and Metabolism
Research Guide
What is Cancer, Lipids, and Metabolism?
Cancer, Lipids, and Metabolism is the study of how lipid metabolic pathways, including fatty acid synthesis, cholesterol metabolism, and enzymes like Fatty Acid Synthase and CD36, contribute to cancer cell pathogenesis, progression, and potential therapeutic targeting.
This field examines metabolic reprogramming in cancer cells involving lipogenesis, cholesterol regulation, and statin effects, with 74,308 works published. Key enzymes such as Fatty Acid Synthase and receptors like CD36 drive tumor growth and vascularization. Ferroptosis, a lipid peroxidation-dependent cell death, links lipid metabolism to cancer regulation, as shown in high-citation studies.
Topic Hierarchy
Research Sub-Topics
Fatty Acid Synthase in Cancer
This sub-topic investigates FASN overexpression, its role in tumor lipogenesis, and inhibitors as therapeutic targets. Researchers explore signaling pathways and preclinical efficacy using cell lines and xenografts.
Cancer Metabolic Reprogramming Lipids
This sub-topic covers lipid alterations in the Warburg-like metabolism of tumors, including de novo synthesis and uptake. Researchers profile metabolomes and link changes to proliferation and metastasis.
Cholesterol Metabolism in Cancer
This sub-topic examines cholesterol synthesis, efflux, and signaling via receptors like SREBP in oncogenesis. Researchers study statins' repurposing and membrane lipid rafts' roles in therapy resistance.
CD36 Receptor in Cancer Lipid Uptake
This sub-topic focuses on CD36-mediated fatty acid uptake promoting metastasis and survival in tumor cells. Researchers validate it in models of breast and prostate cancers, testing blocking antibodies.
Statins in Cancer Therapy
This sub-topic evaluates epidemiological associations, pleiotropic effects, and randomized trials of statins in cancer prevention and treatment. Researchers dissect HMG-CoA reductase inhibition's impacts on inflammation and proliferation.
Why It Matters
Targeting lipid metabolism offers therapeutic strategies for cancer, as statins inhibiting HMG-CoA reductase reduce cholesterol and show efficacy in lowering cardiovascular risks applicable to oncology. Yang et al. (2014) in 'Regulation of Ferroptotic Cancer Cell Death by GPX4' demonstrated GPX4 inhibition induces ferroptosis in cancer cells, providing a mechanism for selective tumor killing with 7013 citations. Stockwell et al. (2017) in 'Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease' connected lipid peroxidation to disease control, cited 6942 times, while Baigent et al. (2005) meta-analysis of 90,056 participants in 'Efficacy and safety of cholesterol-lowering treatment' confirmed statins' safety for broad use, supporting repurposing in cancer trials.
Reading Guide
Where to Start
'Regulation of Ferroptotic Cancer Cell Death by GPX4' by Yang et al. (2014), as it provides a clear entry to lipid peroxidation's role in cancer death with direct experimental evidence on GPX4.
Key Papers Explained
Yang et al. (2014) 'Regulation of Ferroptotic Cancer Cell Death by GPX4' establishes GPX4 as a ferroptosis regulator (7013 citations), built upon by Stockwell et al. (2017) 'Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease' (6942 citations) expanding to disease contexts, and refined in Jiang et al. (2021) 'Ferroptosis: mechanisms, biology and role in disease' (6474 citations) detailing therapeutic roles. Baigent et al. (2005) 'Efficacy and safety of cholesterol-lowering treatment' (6778 citations) complements with clinical statin data relevant to cancer lipid targeting.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Ferroptosis research dominates via GPX4 and lipid peroxidation mechanisms from 2014-2021 papers, but lacks recent preprints. Current frontiers involve integrating statin data with ferroptosis inducers for combination therapies, probing CD36 and Fatty Acid Synthase in metabolic reprogramming.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Estimation of the Concentration of Low-Density Lipoprotein Cho... | 1972 | Clinical Chemistry | 32.1K | ✕ |
| 2 | Angiogenesis in cancer and other diseases | 2000 | Nature | 8.9K | ✕ |
| 3 | THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALL... | 1955 | Journal of Clinical In... | 8.8K | ✓ |
| 4 | Regulation of Ferroptotic Cancer Cell Death by GPX4 | 2014 | Cell | 7.0K | ✓ |
| 5 | Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, ... | 2017 | Cell | 6.9K | ✓ |
| 6 | Efficacy and safety of cholesterol-lowering treatment: prospec... | 2005 | The Lancet | 6.8K | ✕ |
| 7 | Ferroptosis: mechanisms, biology and role in disease | 2021 | Nature Reviews Molecul... | 6.5K | ✓ |
| 8 | Tumor vascular permeability and the EPR effect in macromolecul... | 2000 | Journal of Controlled ... | 6.4K | ✕ |
| 9 | Mechanisms of angiogenesis | 1997 | Nature | 5.7K | ✕ |
| 10 | The Effect of Vitamin E and Beta Carotene on the Incidence of ... | 1994 | New England Journal of... | 4.7K | ✓ |
Frequently Asked Questions
What role does GPX4 play in cancer lipid metabolism?
GPX4 regulates ferroptotic cancer cell death by reducing lipid peroxidation. Yang et al. (2014) in 'Regulation of Ferroptotic Cancer Cell Death by GPX4' showed GPX4 inhibition triggers ferroptosis selectively in tumor cells. This positions GPX4 as a therapeutic target in lipid-dependent cancers.
How do statins relate to cancer treatment?
Statins inhibit HMG-CoA reductase, disrupting cholesterol metabolism essential for cancer growth. Baigent et al. (2005) in 'Efficacy and safety of cholesterol-lowering treatment' analyzed 90,056 participants across 14 trials, confirming statins reduce major vascular events by 21% per LDL reduction. This supports statin repurposing for cancer via lipid pathway interference.
What is ferroptosis in the context of cancer and lipids?
Ferroptosis is an iron-dependent cell death driven by lipid peroxidation. Stockwell et al. (2017) in 'Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease' defined it as a nexus of metabolism and redox biology in disease. Jiang et al. (2021) in 'Ferroptosis: mechanisms, biology and role in disease' outlined its mechanisms for cancer therapy.
How is LDL cholesterol measured in cancer lipid studies?
LDL cholesterol is estimated from total cholesterol, triglycerides, and HDL without ultracentrifugation. Friedewald et al. (1972) in 'Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge' provided the formula still used widely. This method aids lipid profiling in cancer metabolism research.
What is the link between lipid metabolism and cancer angiogenesis?
Lipid metabolism supports tumor vascularization via endothelial growth factors. Carmeliet and Jain (2000) in 'Angiogenesis in cancer and other diseases' detailed how metabolic shifts enable pathological angiogenesis. Risau (1997) in 'Mechanisms of angiogenesis' described VEGF-driven processes influenced by lipid environments.
Open Research Questions
- ? How can GPX4 inhibitors be optimized to induce ferroptosis specifically in cancer cells without systemic toxicity?
- ? What are the precise mechanisms by which statins alter tumor lipid profiles to inhibit progression?
- ? How does CD36 receptor modulation affect fatty acid uptake and metastasis in diverse cancer types?
- ? In what ways does cholesterol metabolism reprogramming vary across cancer stages and types?
- ? Can ferroptosis pathways be combined with lipid-lowering therapies for synergistic cancer treatment?
Recent Trends
The field spans 74,308 works with sustained high citations for ferroptosis papers: Yang et al. at 7013, Stockwell et al. (2017) at 6942, and Jiang et al. (2021) at 6474, indicating persistent focus on lipid peroxidation in cancer.
2014No new preprints or news in the last 6-12 months suggests consolidation around established statin and GPX4 targets.
Research Cancer, Lipids, and Metabolism with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cancer, Lipids, and Metabolism with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers